Douglas Fambrough, Chief Executive Officer at Dicerna Pharmaceuticals Inc (DRNA), sold 278,042 shares at $26.13 ($7.2M) on 2019-12-17, disclosed to the SEC on 2019-12-19.
Open-market sale of $7.2M DRNA by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.13 | 56,716 | $1.5M | 20.5% |
| 2 | $26.13 | 56,716 | $1.5M | 20.5% |
| 3 | $26.94 | 2,305 | $62K | 0.9% |
| 4 | $26.94 | 2,305 | $62K | 0.9% |
| 5 | $25.85 | 78,569 | $2.0M | 28.1% |
| 6 | $25.85 | 78,569 |
| $2.0M |
| 28.1% |
| 7 | $27.07 | 1,431 | $39K | 0.5% |
| 8 | $27.07 | 1,431 | $39K | 0.5% |
| Total | $26.00 avg | 278,042 | $7.2M | 100% |
| Filing → |
| DRNA | BUY | 2016-11-16 | $123K | — | Filing → |
| DRNA | BUY | 2014-02-20 | $75K | — | Filing → |